Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1729 results found. Search for [ pharmaceutical company ]

Results 1 to 21 of 1729
BusinessToday.In
November 30, 2020
PM Modi asks teams to come out with ideas on regulatory processes and related matters. As pharma companies move ahead with their clinical trials, the government has also stepped up efforts to devise the vaccine distribution plan


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


PTI
November 29, 2020
The legal notice has been sent to Pune based Serum Institute of India, which has collaborated with Oxford University and Astra Zeneca, a pharmaceutical company, in connection with making of the vaccine, 'Covidshield.'


PTI
November 29, 2020
India has a big market that needs to upgrade and set up for 5G offtake, and the government and policy makers can trigger growth of the telecom space by releasing spectrum, a senior official of Qualcomm has said


BusinessToday.In
November 28, 2020
PM Modi paid his visit to Pune-based Serum Institute of India and reviewed the manufacturing process of COVID-19 vaccine. He interacted with scientists at the SII and went around the facility, taking stock of vaccine development work


BusinessToday.In
November 28, 2020
PM Modi took stock of the work being done so far on the development of coronavirus vaccine at the Zydus Cadila research centre


Reuters
November 28, 2020
Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of \"cutting corners\", said Thomas Cueni, director-general of the IFPMA


Manoj Sharma
November 27, 2020
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band


Aseem Thapliyal
November 27, 2020
An investment of Rs 1 lakh in the share a year ago would have grown to Rs 4.51 lakh today


Reuters
November 27, 2020
Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021


BusinessToday.In
November 27, 2020
The Russian Gamaleya research institute, the creator of Sputnik V vaccine for COVID-19, has suggested to UK pharmaceutical company AstraZeneca to try to boost the efficacy of its COVID-19 vaccine, combining it with a shot of its own vaccine.


PB Jayakumar
November 25, 2020
Laurus is one of India's leading manufacturers of active pharmaceutical ingredients (API) for Anti-Retroviral (ARV), Oncology, Cardiovascular, Anti-Diabetics, Anti-Asthma and Gastroenterology medicines, besides pharmaceutical contract manufacturing services


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 24, 2020
Market cap of the firm rose to Rs 32,863 crore as against Rs 29,358 crore clocked on listing day.


BusinessToday.In
November 24, 2020
Serum Institute has tied up with British-Swedish pharmaceutical firm AstraZeneca and the University of Oxford to mass-produce the Covishield vaccine to fight back COVID-19 virus


BusinessToday.In
November 24, 2020
India Stock Market Highlights Today: During the session, Sensex hit a lifetime high of 44,601 and Nifty touched record high of 13,079


BusinessToday.In
November 23, 2020
Indian Council of Medical Research is working closely with SII for Covishield vaccine trials across 15 centres in India, and would also be funding the clinical trials in the country.


BusinessToday.In
November 23, 2020
It has been found that one of the vaccine's dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply, says AstraZeneca


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


PAGES 1 OF 87  12345